Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 3223-3224 [2025-00391]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices
measures that ask beneficiaries about
health outcomes related to specific
mental and Physical Conditions. Form
Number: CMS–10203 (OMB control
number: 0938–0701); Frequency: Yearly;
Affected Public: Individuals and
Households; Number of Respondents:
1,275; Total Annual Responses:
663,150; Total Annual Hours: 212,208.
(For policy questions regarding this
collection contact Alyssa Rosen at 410–
786–8559 or Alyssa.Rosen@
cms.hhs.gov.)
William N. Parham, III
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2025–00589 Filed 1–13–25; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3472–N]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice announces the
request for nominations for membership
on the Medicare Evidence Development
& Coverage Advisory Committee
(MEDCAC). Among other duties, the
MEDCAC provides advice and guidance
to the Secretary of the Department of
Health and Human Services (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) concerning the
adequacy of scientific evidence
available to CMS in making coverage
determinations under the Medicare
program.
The MEDCAC’s fundamental purpose
is to support the principles of an
evidence-based determination process
for Medicare’s coverage policies.
MEDCAC panels provide advice to CMS
on the strength of the evidence available
for specific medical treatments and
technologies through a public,
participatory, and accountable process.
DATES: Nominations must be received
by Monday, February 17, 2025.
ADDRESSES: You may send in
nominations for membership via email
to MEDCACnomination@cms.hhs.gov.
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
22:42 Jan 13, 2025
Jkt 265001
FOR FURTHER INFORMATION CONTACT:
Leah Cromwell, 410–786–2243,
MEDCAC Coordinator, via email at
Leah.Cromwell1@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial
charter for the Medicare Coverage
Advisory Committee (MCAC) on
November 24, 1998. A notice in the
Federal Register (63 FR 68780)
announcing establishment of the MCAC
was published on December 14, 1998.
The MCAC name was updated to more
accurately reflect the purpose of the
committee and on January 26, 2007, the
Secretary published a notice in the
Federal Register (72 FR 3853),
announcing that the Committee’s name
changed to the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC). The current
Secretary’s Charter for the MEDCAC is
available on the CMS website at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/Downloads/
medcaccharter.pdf or you may obtain a
copy of the charter by submitting a
request to the contact listed in the FOR
FURTHER INFORMATION section of this
notice.
The MEDCAC is governed by
provisions of the Federal Advisory
Committee Act, Pub. L. 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and
use of advisory committees, and is
authorized by section 222 of the Public
Health Service Act as amended (42
U.S.C. 217A).
We are requesting nominations for
candidates to serve on the MEDCAC.
Nominees are selected based upon their
individual qualifications and not solely
as representatives of professional
associations or societies. We wish to
ensure adequate representation of those
enrolled in the Medicare program
including but not limited to, racial and
ethnic groups, individuals with
disabilities, and from across the gender
spectrum. Therefore, we encourage
nominations of qualified candidates
who can represent these lived
experiences.
The MEDCAC consists of a pool of
100 appointed members including: 90
at-large standing members (20 of whom
are patient advocates), and 10
representatives of industry interests.
Members generally are recognized
authorities in clinical medicine
including subspecialties, administrative
medicine, public health, biological and
physical sciences, epidemiology and
biostatistics, clinical trial design, health
care data management and analysis,
patient advocacy, health care
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
3223
economics, health disparities, medical
ethics, geriatrics those with an
understanding of sociodemographic bias
and resulting limitations of scientific
evidence, or other relevant professions.
The MEDCAC works from an agenda
provided by the Designated Federal
Official. The MEDCAC reviews and
evaluates medical literature and
technology assessments, and hears
public testimony on the evidence
available to address the impact of
medical items and services on health
outcomes of Medicare beneficiaries. The
MEDCAC may also advise the Centers
for Medicare & Medicaid Services (CMS)
as part of Medicare’s ‘‘coverage with
evidence development’’ initiative.
II. Provisions of the Notice
As of December 2025, there will be a
total of 20 membership terms expiring.
Of the 20 memberships expiring, 2 are
industry representatives, 10 are patient
advocates and the remaining 8
membership openings are for the atlarge standing MEDCAC membership.
All nominations must be
accompanied by curricula vitae.
Nomination packages should be
addressed to Leah Cromwell and sent to
the email address listed in the
ADDRESSES section of this notice.
Nominees are selected based upon their
individual qualifications.
Nominees for membership must have
expertise and experience in one or more
of the following fields:
• Clinical medicine including
subspecialties
• Administrative medicine
• Public health
• Health disparities
• Biological and physical sciences
• Epidemiology and biostatistics
• Clinical trial design
• Health care data management and
analysis
• Patient advocacy
• Health care economics
• Medical ethics
• Geriatrics
• Other relevant professions
We are looking particularly for
experts in a number of fields. These
include health disparities, cancer
screening, genetic testing, clinical
epidemiology, psychopharmacology,
screening and diagnostic testing
analysis, and vascular surgery. We also
need experts in biostatistics in clinical
settings, dementia treatment,
observational research design, stroke
epidemiology, geriatrics, and women’s
health.
The nomination letter must include a
statement that the nominee is willing to
serve as a member of the MEDCAC and
E:\FR\FM\14JAN1.SGM
14JAN1
3224
Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices
khammond on DSK9W7S144PROD with NOTICES
appears to have no conflict of interest
that would preclude membership.
We are requesting that all curricula
vitae include the following:
• List of areas of expertise
• Title and current position
• Professional affiliation
• Home and business address
• Telephone numbers (Please specify if
the number is for: home, office, or cell
phone)
• Email address (Please specify if the
email address is for work/personal)
In the nomination letter, we are
requesting that nominees specify
whether they are applying for a patient
advocate position, an at-large standing
position, or as an industry
representative. Potential candidates will
be asked to provide detailed information
concerning such matters as financial
holdings, consultancies, and research
grants or contracts in order to permit
evaluation of possible sources of
financial conflict of interest. Department
policy prohibits multiple committee
memberships. A federal advisory
committee member may not serve on
more than one committee within an
agency at the same time.
Members may be invited to serve for
overlapping 2-year terms. A member
may continue to serve after the
expiration of the member’s term until a
successor is named. Any interested
person may nominate one or more
qualified persons. Self-nominations are
also accepted. Individuals interested in
the representative positions are
encouraged to include a letter of support
from the organization or interest group
they would represent.
III. Collection of Information
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Chief Medical Officer and
Director of the Center for Clinical
Standards and Quality for the Centers
for Medicare & Medicaid Services
(CMS), Dora Hughes, having reviewed
and approved this document, authorizes
Chyana Woodyard, who is the Federal
Register Liaison, to electronically sign
this document for purposes of
publication in the Federal Register.
Chyana Woodyard,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2025–00391 Filed 1–13–25; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
22:42 Jan 13, 2025
Jkt 265001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Tribal Maternal, Infant, and
Early Childhood Home Visiting
(MIECHV) Program Community Needs
and Readiness Assessment Guidance
and Implementation Plan Guidance
(Office of Management and Budget#:
0970–0611)
Office of Early Childhood
Development, Administration for
Children and Families, U.S. Department
of Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families (ACF), Office of
Early Childhood Development (ECD) is
requesting revisions to the Tribal
Maternal, Infant, and Early Childhood
Home Visiting Program Community
Needs and Readiness Assessment
Guidance and Implementation Plan
Guidance (Office of Management and
Budget (OMB) #: 0970–0611; expiration
June 30, 2026) and a 3-year extension of
approval.
DATES: Comments due March 17, 2025.
In compliance with the requirements of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: Section 511(e)(8)(A) of
title V of the Social Security Act
requires that grantees under the Tribal
MIECHV program, in the first year of
their grants, submit an implementation
plan on how they will meet the
requirements of the program. Section
511(h)(2)(A) further states that the
requirements for the MIECHV grants to
Tribes, Tribal organizations, and urban
Indian organizations are to be
consistent, to the greatest extent
practicable, with the requirements for
grantees under the MIECHV program for
states and jurisdictions.
ACF ECD, in collaboration with the
Health Resources and Services
Administration’s Maternal and Child
Health Bureau, awarded grants for the
Tribal MIECHV Program (Tribal Home
Visiting) to support cooperative
agreements to conduct community
SUMMARY:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
needs assessments; plan for and
implement high-quality, culturally
relevant, evidence-based home visiting
programs in at-risk Tribal communities;
establish, measure, and report on
progress toward meeting performance
measures in six legislatively mandated
benchmark areas; and conduct rigorous
evaluation activities to build the
knowledge base on home visiting among
Native populations.
During the first grant year, Tribal
Home Visiting grantees must comply
with the requirement to conduct a
Community Needs and Readiness
Assessment (CNRA) and submit an
implementation plan that should feature
planned activities to be carried out
under the program in years 2–5 of their
cooperative agreements. To assist
grantees with meeting these
requirements, ACF created a CNRA and
implementation guidance for grantees to
use when writing their plans. The
CNRA Guidance and Implementation
Plan Guidance (IPG) specifies that
grantees must provide a plan to address
the following areas:
•
•
•
•
CNRA
Program Design
Program Blueprint
Plan for Data Collection, Management,
and Performance Measurement
• Fidelity Monitoring and Quality
Assurance
The previous guidance included
information about the CNRA and the
implementation plan for grant
recipients. This extension request
updates the guidance by separating the
CNRA Guidance from the IPG. This
separation allows the CNRA Guidance
to function as an independent
document, enhancing clarity and
usability instead of being incorporated
within the IPG.
Additionally, significant
modifications have been made to the
guidance compared to earlier versions,
with a primary focus on reducing the
burden on grant recipients. These
changes include eliminating redundant
sections that overlap with other
reporting requirements, reducing the
number of guiding questions, and
allowing for shorter responses.
Respondents: Tribal Home Visiting
Managers (information collection does
not include direct interaction with
individuals or families that receive the
services).
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 90, Number 8 (Tuesday, January 14, 2025)]
[Notices]
[Pages 3223-3224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00391]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3472-N]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee
AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the request for nominations for
membership on the Medicare Evidence Development & Coverage Advisory
Committee (MEDCAC). Among other duties, the MEDCAC provides advice and
guidance to the Secretary of the Department of Health and Human
Services (the Secretary) and the Administrator of the Centers for
Medicare & Medicaid Services (CMS) concerning the adequacy of
scientific evidence available to CMS in making coverage determinations
under the Medicare program.
The MEDCAC's fundamental purpose is to support the principles of an
evidence-based determination process for Medicare's coverage policies.
MEDCAC panels provide advice to CMS on the strength of the evidence
available for specific medical treatments and technologies through a
public, participatory, and accountable process.
DATES: Nominations must be received by Monday, February 17, 2025.
ADDRESSES: You may send in nominations for membership via email to
[email protected].
FOR FURTHER INFORMATION CONTACT: Leah Cromwell, 410-786-2243, MEDCAC
Coordinator, via email at [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial charter for the Medicare Coverage
Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal
Register (63 FR 68780) announcing establishment of the MCAC was
published on December 14, 1998. The MCAC name was updated to more
accurately reflect the purpose of the committee and on January 26,
2007, the Secretary published a notice in the Federal Register (72 FR
3853), announcing that the Committee's name changed to the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC). The
current Secretary's Charter for the MEDCAC is available on the CMS
website at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/Downloads/medcaccharter.pdf or you may obtain a copy of the charter by
submitting a request to the contact listed in the FOR FURTHER
INFORMATION section of this notice.
The MEDCAC is governed by provisions of the Federal Advisory
Committee Act, Pub. L. 92-463, as amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and use of advisory committees, and
is authorized by section 222 of the Public Health Service Act as
amended (42 U.S.C. 217A).
We are requesting nominations for candidates to serve on the
MEDCAC. Nominees are selected based upon their individual
qualifications and not solely as representatives of professional
associations or societies. We wish to ensure adequate representation of
those enrolled in the Medicare program including but not limited to,
racial and ethnic groups, individuals with disabilities, and from
across the gender spectrum. Therefore, we encourage nominations of
qualified candidates who can represent these lived experiences.
The MEDCAC consists of a pool of 100 appointed members including:
90 at-large standing members (20 of whom are patient advocates), and 10
representatives of industry interests. Members generally are recognized
authorities in clinical medicine including subspecialties,
administrative medicine, public health, biological and physical
sciences, epidemiology and biostatistics, clinical trial design, health
care data management and analysis, patient advocacy, health care
economics, health disparities, medical ethics, geriatrics those with an
understanding of sociodemographic bias and resulting limitations of
scientific evidence, or other relevant professions.
The MEDCAC works from an agenda provided by the Designated Federal
Official. The MEDCAC reviews and evaluates medical literature and
technology assessments, and hears public testimony on the evidence
available to address the impact of medical items and services on health
outcomes of Medicare beneficiaries. The MEDCAC may also advise the
Centers for Medicare & Medicaid Services (CMS) as part of Medicare's
``coverage with evidence development'' initiative.
II. Provisions of the Notice
As of December 2025, there will be a total of 20 membership terms
expiring. Of the 20 memberships expiring, 2 are industry
representatives, 10 are patient advocates and the remaining 8
membership openings are for the at-large standing MEDCAC membership.
All nominations must be accompanied by curricula vitae. Nomination
packages should be addressed to Leah Cromwell and sent to the email
address listed in the ADDRESSES section of this notice. Nominees are
selected based upon their individual qualifications.
Nominees for membership must have expertise and experience in one
or more of the following fields:
Clinical medicine including subspecialties
Administrative medicine
Public health
Health disparities
Biological and physical sciences
Epidemiology and biostatistics
Clinical trial design
Health care data management and analysis
Patient advocacy
Health care economics
Medical ethics
Geriatrics
Other relevant professions
We are looking particularly for experts in a number of fields.
These include health disparities, cancer screening, genetic testing,
clinical epidemiology, psychopharmacology, screening and diagnostic
testing analysis, and vascular surgery. We also need experts in
biostatistics in clinical settings, dementia treatment, observational
research design, stroke epidemiology, geriatrics, and women's health.
The nomination letter must include a statement that the nominee is
willing to serve as a member of the MEDCAC and
[[Page 3224]]
appears to have no conflict of interest that would preclude membership.
We are requesting that all curricula vitae include the following:
List of areas of expertise
Title and current position
Professional affiliation
Home and business address
Telephone numbers (Please specify if the number is for: home,
office, or cell phone)
Email address (Please specify if the email address is for
work/personal)
In the nomination letter, we are requesting that nominees specify
whether they are applying for a patient advocate position, an at-large
standing position, or as an industry representative. Potential
candidates will be asked to provide detailed information concerning
such matters as financial holdings, consultancies, and research grants
or contracts in order to permit evaluation of possible sources of
financial conflict of interest. Department policy prohibits multiple
committee memberships. A federal advisory committee member may not
serve on more than one committee within an agency at the same time.
Members may be invited to serve for overlapping 2-year terms. A
member may continue to serve after the expiration of the member's term
until a successor is named. Any interested person may nominate one or
more qualified persons. Self-nominations are also accepted. Individuals
interested in the representative positions are encouraged to include a
letter of support from the organization or interest group they would
represent.
III. Collection of Information
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
The Chief Medical Officer and Director of the Center for Clinical
Standards and Quality for the Centers for Medicare & Medicaid Services
(CMS), Dora Hughes, having reviewed and approved this document,
authorizes Chyana Woodyard, who is the Federal Register Liaison, to
electronically sign this document for purposes of publication in the
Federal Register.
Chyana Woodyard,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2025-00391 Filed 1-13-25; 8:45 am]
BILLING CODE 4120-01-P
